Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 12/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.38 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3368045 | 0.95 | EGLN1 (0.65) | EGLN1HPGD | |
| SCHEMBL3369914 | 0.92 | EGLN1 (0.71) | EGLN1HPGDCA1CA2HSD17B2 | |
| SCHEMBL3368761 | 0.91 | EGLN1 (0.60) | EGLN1ERCC1ERCC4 | |
| SCHEMBL3367694 | 0.89 | EGLN1 (0.63) | EGLN1SMN1; SMN2KMT2A | |
| SCHEMBL3366533 | 0.88 | EGLN1 (0.57) | EGLN1KMT2AGLA | |
| SCHEMBL3368645 | 0.85 | EGLN1 (0.67) | EGLN1ERCC1ERCC4 | |
| SCHEMBL3366469 | 0.85 | EGLN1 (0.72) | EGLN1 | |
| SCHEMBL3367971 | 0.85 | EGLN1 (0.78) | EGLN1 | |
| SCHEMBL3366064 | 0.85 | EGLN1 (0.63) | EGLN1ERCC1ERCC4KMT2A | |
| SCHEMBL3371453 | 0.84 | EGLN1 (0.68) | EGLN1HPGDCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010018458-A2 | PHENOL DERIVATIVES AND METHODS OF USE THEREOF | CRYSTALGENOMICS, INC. (KR) | 2010-02-18 | — | — | WO | claimed |
| WO-2010018458-A2 | PHENOL DERIVATIVES AND METHODS OF USE THEREOF | CRYSTALGENOMICS, INC. (KR) | 2010-02-18 | — | — | WO | disclosed |